US 8372802
Fluorinated macrocyclic compounds as hepatitis C virus inhibitors
granted A61KA61K38/00A61P
Quick answer
US patent 8372802 (Fluorinated macrocyclic compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12, A61P31/14